Retinopathy of Prematurity (ROP) Completed Phase 2 Trials for Mecasermin rinfabate (DB14751)

Also known as: ROP - Retinopathy of Prematurity / Retinopathy of Prematurity / Retrolental fibroplasia / Retinopathy of prematurity (disorder) / Retinopathy of prematurity NOS / Retrolental fibroplasia (disorder)

IndicationStatusPhase
DBCOND0046296 (Retinopathy of Prematurity (ROP))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02386839Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)Treatment
NCT01096784IGF-1/IGFBP3 Prevention of Retinopathy of PrematurityPrevention